This report shows patients by high and moderate risk as defined by ATAGI and utilised in the national roadmap.

It uses the same categories as the 'General' COVID-19 report:

• Dose 1 Categories
  • Dose 1 Astrazeneca 
  • Dose 1 Pfizer (Comirnaty)
  • Dose 1 Moderna (Spikevax)
  • Dose 1 Other
• Dose 2 Categories
  • Dose 2 Astrazeneca 
  • Dose 2 Pfizer (Comirnaty)
  • Dose 2 Moderna (Spikevax)
  • Dose 2 Other
• Declined 
• Not Recorded

We are using the following criteria to determine high and medium risk (from https://www.healthdirect.gov.au/coronavirus-covid-19-groups-at-higher-risk-faqs):

People are at high risk of serious illness from COVID-19 if they:

• are age 70 years and older
• have had an organ transplant and are on immune suppressive therapy
• have had a bone marrow transplant in the past 24 months
• are on immune suppressive therapy for graft versus host disease
• have had a blood cancer — for example, leukaemia, lymphoma or myelodysplastic syndrome — in the past 5 years
• are having chemotherapy or radiotherapy

People are at moderate risk of serious illness from COVID-19 if they have:

• chronic kidney failure
• heart disease
• chronic lung disease — but excluding mild or moderate asthma
• a non-blood cancer in the past 12 months
• diabetes
• severe obesity with a BMI (body mass index) of 40 or more
• chronic liver disease
• some neurological conditions such as stroke or dementia
• some chronic inflammatory conditions and treatments
• other primary or acquired immunodeficiencies